NEWSBRIEF: Syrrx Sues Oculus for Patent Infringement | GenomeWeb

NEW YORK, May 1 - Syrrx today said it has filed a patent-infringement suit against Oculus Pharmaceuticals.


The suit, filed in the US District Court of Delaware, claims that Oculus used certain "nanovolume technologies" patented by Syrrx.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.